Serological response 5 months after the BNT162b2 COVID-19 vaccination in patients with various hematological disorders in Japan
CONCLUSION: Our study shows that patients with hematological disorders are at risk of developing severe COVID-19 infections because of low responsiveness to vaccination. Moreover, the rate of antibody positivity differed between the disease groups. Further studies are warranted to determine an appropriate preventive method for these patients, especially those with B-NHL.PMID:38025915 | PMC:PMC10655153 | DOI:10.7774/cevr.2023.12.4.319
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Yoshiaki Marumo Takashi Yoshida Yuki Furukawa Kenji Ina Ayumi Kamiya Takae Kataoka Satoshi Kayukawa Source Type: research
More News: Acute Leukemia | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Coronavirus | Covid Vaccine | COVID-19 | Hematology | Hodgkin's Disease | Japan Health | Leukemia | Lymphoma | Myeloma | Non-Hodgkin's Lymphoma | Respiratory Medicine | SARS | Study | Vaccines